Unacylated Ghrelin to Improve FuncTioning in PAD: The GIFT Trial
Status:
Completed
Trial end date:
2017-08-30
Target enrollment:
Participant gender:
Summary
The GIFT pilot study will investigate the optimal subcutaneous dose and safety of
subcutaneously administered unacylated ghrelin in older people with peripheral artery disease
(PAD).